Page 124 - GPD-4-2
P. 124

Gene & Protein in Disease                                             Pediatric glioma circadian clock genes



            particularly dangerous when they metastasize, forming   that  are currently being  tested as  acting through core
            secondary tumors in the meninges and elsewhere. 107  circadian clock genes could also prove effective in treating
              As described in an extensive review of GSCs in   pediatric GBM and LG tumors. The lack of  PER2 and
            medulloblastomas,   GSCs  are  present  in  all  four   PER3 repression in pediatric GBM and LG tumors, along
                           108
            medulloblastoma subtypes, and distinguishable GSC   with other differences, suggests that an alternative drug
            categories are present. For example, cells expressing   development approach specific for pediatric gliomas may
                                                               be needed. The overexpression of TIMELESS in all three
            either of the GSC markers CD133 and CD114 appear as   glioma categories indicates another possible path for
            distinct  cell  populations.  Anticancer  treatments  acting   effective drug development. Finally, the higher clock gene
            through epigenetic modifications of genes that maintain   expression in MB tumors detected in the Group  3 and
            stemness are being tested, particularly histone deacetylase   Group 4 subtypes, and with adolescent onset, may provide
                    109
            inhibitors.  Organoid cultures have been developed to   opportunities for specialized treatments.
            address the role of GSCs in medulloblastoma and other
            pediatric gliomas.                                 Acknowledgments

            4.5. Limitations of the current study and future   We thank the additional graduate and undergraduate
            directions for exploration                         researchers who participated in useful discussions, that
            The present study preliminarily explored circadian clock   were valuable contributions to this study.
            gene expression in some of the most common pediatric   Funding
            gliomas, embarking on a journey to address the knowledge
            gap. It is important to continue this approach by examining   Support for this project was provided internally by Bowling
            additional samples from DIPG, currently known as   Green State University through assistance with computer
            diffuse midline glioma (DMG), which is a pHGG that is   technology.
            histologically similar to GBM,  highly lethal, and has   Conflict of interest
                                     110
            poor treatment options. DIPG is often medically treated
            like GBM, resulting in poor outcomes, but is distinctly   The authors declare that they have no competing interests.
            different and is reported to consist of three subgroups.
                                                         36
            Our preliminary results suggest that some of the clinically   Author contributions
            relevant differences between pediatric GBM and DIPG   Conceptualization: All authors
            may be their differential expression of circadian clock   Investigation: Austin Tyler Vogt, Veda Sanjay Mohite,
            genes.                                                Michael Eric Geusz
              Some medications that target glioma subtypes are   Methodology: All authors
            being tested, such as against the SSH MB subtype.  It may   Writing – original draft: Austin Tyler Vogt, Veda Sanjay
                                                    57
            be useful to further target subtypes by exploiting their   Mohite, Michael Eric Geusz
            differences in clock gene expression and potential for   Writing – review & editing: All authors
            circadian rhythmicity, as suggested by the current study.   Ethics approval and consent to participate
            Most importantly, because of the daily oscillations in
            activity of members of the circadian gene set, they should   Not applicable.
            be evaluated in respect to the time of day when samples
            were collected and, perhaps, at some future point, the   Consent for publication
            phase of circadian  clocks  assayed  in situ within  patient   Not applicable. All datasets were derived from data
            tumors. More detailed proteomics of the oscillating clock   repositories available to the public.
            components within tumors is also needed because of the
            many post-transcriptional effects that can impact circadian   Availability of data
            rhythms. 111                                       Original data used in this study can be obtained from the

            5. Conclusion                                      GlioVis data portal for visualization and analysis of brain
                                                               tumor expression datasets (http://gliovis.bioinfo.cnio.es/),
            Pediatric and adult gliomas show some similarity in their   the TIMER2.0 website, (http://timer.comp-genomics.org/
            expression of core and related circadian clock genes. CRY2   timer/), GEO (https://www.ncbi.nlm.nih.gov/geo/info/
            and RORB are the two core clock genes that are suppressed   geo2r.html), and the University of California, Santa Cruz
            in all three glioma categories: adult GBM, pediatric   Cell  Explorer  website  (https://www.pneuroonccellatlas.
            GBM, and LG glioma. Consequently, pharmaceuticals   org/). The collected and analyzed data are available from


            Volume 4 Issue 2 (2025)                         18                               doi: 10.36922/gpd.4112
   119   120   121   122   123   124   125   126   127   128   129